Cargando…

The ARV roll out and the disability grant: a South African dilemma?

BACKGROUND: Prior to the antiretroviral (ARV) drug roll out in 2004, people living with HIV (PLHIV) in South Africa received disability grants when they were defined as "AIDS-sick". In the absence of available and effective medication, a diagnosis of AIDS portended disability. The disabili...

Descripción completa

Detalles Bibliográficos
Autores principales: de Paoli, Marina Manuela, Mills, Elizabeth Anne, Grønningsæter, Arne Backer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305561/
https://www.ncbi.nlm.nih.gov/pubmed/22340659
http://dx.doi.org/10.1186/1758-2652-15-6
_version_ 1782227096959975424
author de Paoli, Marina Manuela
Mills, Elizabeth Anne
Grønningsæter, Arne Backer
author_facet de Paoli, Marina Manuela
Mills, Elizabeth Anne
Grønningsæter, Arne Backer
author_sort de Paoli, Marina Manuela
collection PubMed
description BACKGROUND: Prior to the antiretroviral (ARV) drug roll out in 2004, people living with HIV (PLHIV) in South Africa received disability grants when they were defined as "AIDS-sick". In the absence of available and effective medication, a diagnosis of AIDS portended disability. The disability grant is a critical component of South Africa's social security system, and plays an important role in addressing poverty among PLHIV. Given the prevalence of unemployment and poverty, disability grants ensure access to essential resources, like food, for PLHIV. Following the ARV roll out in South Africa, PLHIV experienced improved health that, in turn, affected their grant eligibility. Our aim is to explore whether PLHIV reduced or stopped treatment to remain eligible for the disability grant from the perspectives of both PLHIV and their doctors. METHODS: A mixed-methods design with concurrent triangulation was applied. We conducted: (1) in-depth semi-structured interviews with 29 PLHIV; (2) in-depth semi-structured interviews with eight medical doctors working in the public sector throughout the Cape Peninsula; (3) three focus group discussions with programme managers, stakeholders and community workers; and (4) a panel survey of 216 PLHIV receiving ARVs. RESULTS: Unemployment and poverty were the primary concerns for PLHIV and the disability grant was viewed as a temporary way out of this vicious cycle. Although loss of the disability grant significantly affected the well-being of PLHIV, they did not discontinue ARVs. However, in a number of subtle ways, PLHIV "tipped the scales" to lower the CD4 count without stopping ARVs completely. Grant criteria were deemed ad hoc, and doctors struggled to balance economic and physical welfare when assessing eligibility. CONCLUSIONS: It is crucial to provide sustainable economic support in conjunction with ARVs in order to make "positive living" a reality for PLHIV. A chronic illness grant, a basic income grant or an unemployment grant could provide viable alternatives when the PLHIV are no longer eligible for a disability grant.
format Online
Article
Text
id pubmed-3305561
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-33055612012-03-16 The ARV roll out and the disability grant: a South African dilemma? de Paoli, Marina Manuela Mills, Elizabeth Anne Grønningsæter, Arne Backer J Int AIDS Soc Research BACKGROUND: Prior to the antiretroviral (ARV) drug roll out in 2004, people living with HIV (PLHIV) in South Africa received disability grants when they were defined as "AIDS-sick". In the absence of available and effective medication, a diagnosis of AIDS portended disability. The disability grant is a critical component of South Africa's social security system, and plays an important role in addressing poverty among PLHIV. Given the prevalence of unemployment and poverty, disability grants ensure access to essential resources, like food, for PLHIV. Following the ARV roll out in South Africa, PLHIV experienced improved health that, in turn, affected their grant eligibility. Our aim is to explore whether PLHIV reduced or stopped treatment to remain eligible for the disability grant from the perspectives of both PLHIV and their doctors. METHODS: A mixed-methods design with concurrent triangulation was applied. We conducted: (1) in-depth semi-structured interviews with 29 PLHIV; (2) in-depth semi-structured interviews with eight medical doctors working in the public sector throughout the Cape Peninsula; (3) three focus group discussions with programme managers, stakeholders and community workers; and (4) a panel survey of 216 PLHIV receiving ARVs. RESULTS: Unemployment and poverty were the primary concerns for PLHIV and the disability grant was viewed as a temporary way out of this vicious cycle. Although loss of the disability grant significantly affected the well-being of PLHIV, they did not discontinue ARVs. However, in a number of subtle ways, PLHIV "tipped the scales" to lower the CD4 count without stopping ARVs completely. Grant criteria were deemed ad hoc, and doctors struggled to balance economic and physical welfare when assessing eligibility. CONCLUSIONS: It is crucial to provide sustainable economic support in conjunction with ARVs in order to make "positive living" a reality for PLHIV. A chronic illness grant, a basic income grant or an unemployment grant could provide viable alternatives when the PLHIV are no longer eligible for a disability grant. The International AIDS Society 2012-02-16 /pmc/articles/PMC3305561/ /pubmed/22340659 http://dx.doi.org/10.1186/1758-2652-15-6 Text en Copyright ©2012 de Paoli et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
de Paoli, Marina Manuela
Mills, Elizabeth Anne
Grønningsæter, Arne Backer
The ARV roll out and the disability grant: a South African dilemma?
title The ARV roll out and the disability grant: a South African dilemma?
title_full The ARV roll out and the disability grant: a South African dilemma?
title_fullStr The ARV roll out and the disability grant: a South African dilemma?
title_full_unstemmed The ARV roll out and the disability grant: a South African dilemma?
title_short The ARV roll out and the disability grant: a South African dilemma?
title_sort arv roll out and the disability grant: a south african dilemma?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305561/
https://www.ncbi.nlm.nih.gov/pubmed/22340659
http://dx.doi.org/10.1186/1758-2652-15-6
work_keys_str_mv AT depaolimarinamanuela thearvrolloutandthedisabilitygrantasouthafricandilemma
AT millselizabethanne thearvrolloutandthedisabilitygrantasouthafricandilemma
AT grønningsæterarnebacker thearvrolloutandthedisabilitygrantasouthafricandilemma
AT depaolimarinamanuela arvrolloutandthedisabilitygrantasouthafricandilemma
AT millselizabethanne arvrolloutandthedisabilitygrantasouthafricandilemma
AT grønningsæterarnebacker arvrolloutandthedisabilitygrantasouthafricandilemma